✦ LIBER ✦

P397 Outcomes after dose escalation of infliximab in Japanese patients with Crohn's disease

✍ Scribed by Sako, M.; Kawaguchi, T.; Hirayama, A.; Fukushi, G.; Hayama, K.; Fujiwara, T.; Yoshimura, N.; Takazoe, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P430 Long-term outcome of Crohn's diseas

✍ Chen, B.L.; Lv, S.C.; Feng, T.; Li, M.Y.; Rao, P.S.; Zeng, Z.R.; Hu, P.J.; Chen, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 51 KB

P352 Need for infliximab dose intensific

✍ C. Taxonera; D. Olivares; J.L. Mendoza; M. Cañas; F. Estremera; M. Díaz-Rubio 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 61 KB

W1335 Previous Non-Response to Inflixima

✍ Bultman, Evelien; West, Rachel L.; van Liere-Baron, Astrid; Kuipers, Ernst J.; Z 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 103 KB

P016 FLEXIBILITY IN INTERVAL AND DOSING

✍ F. Schnitzler; H. Fidder; M. Ferrante; M. Noman; G. Van Assche; I. Hoffman; S. V 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 66 KB

P367 Rate of and response to dose escala

✍ Dubinsky, M.; Rosh, J.; Faubion, W.A.; Kierkus, J.; Ruemmele, F.; Hyams, J.; Eic 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 53 KB

P-096: Rate of and response to dose esca

✍ Dubinsky, M.; Rosh, J.; Faubion, W.A.; Kierkus, J.; Ruemmele, F.; Hyams, J.S.; E 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 47 KB